颈动脉支架置入术中开放型与闭合型支架网孔设计的比较:CREST-2注册研究
CREST-2注册研究比较了开放型与闭合型支架在颈动脉支架置入术中的临床结局。共纳入5307例手术,开放型支架组2054例(38.7%),闭合型支架组3253例(61.3%)。调整后,在原发性病变中开放型支架的围手术期卒中或死亡显著高于闭合型支架(3.5/100例 vs 2.2%,OR 1.59,95%CI 1.13-2.23,P<.01),而在再狭窄病变中两组无显著差异。
要点
- 在原发性病变中,开放型支架的围手术期卒中或死亡显著高于闭合型支架(OR 1.59,95%CI 1.13-2.23,P<.01)。
- 在再狭窄病变中,开放型与闭合型支架的围手术期卒中或死亡无显著差异(OR 0.31,95%CI 0.09-1.01,P=.052)。
- 支架设计影响颈动脉支架置入术的围手术期卒中或死亡,闭合型支架在治疗原发性动脉粥样硬化时事件率更低。
核心结论
- 支架设计影响颈动脉支架置入术的围手术期卒中或死亡,闭合型支架在治疗原发性动脉粥样硬化时事件率更低,但在再狭窄病变中无此差异。
研究设计与样本
- CREST-2注册研究纳入因手术高风险或患者偏好而选择颈动脉支架置入术的无症状和有症状患者,实施术者和中心认证、病变筛选及标准化操作方案,记录患者特征、手术细节和结局。
- 共分析5307例手术,由101个临床中心的163名介入医生完成,其中2054例(38.7%)使用开放型支架,3253例(61.3%)使用闭合型支架。
- 使用多变量逻辑回归评估支架网孔设计与围手术期(30天)卒中或死亡的关系。
主要发现
- 围手术期91例患者(1.7%)发生卒中(其中3例致死),16例患者(0.4%)死亡且未发生卒中。
- 调整年龄、性别、症状状态、病例紧急程度及适应证效应修饰后,原发性病变中开放型支架的围手术期卒中或死亡为每100例3.5事件(95%CI 2.6-4.7),闭合型支架为2.2%(95%CI 1.6-3.0),开放型较闭合型显著升高(OR 1.59,95%CI 1.13-2.23,P<.01)。
- 再狭窄病变中,开放型支架的围手术期卒中或死亡为1.2%(95%CI 0.4-3.3),闭合型支架为4.0%(95%CI 2.2-7.2),两组无显著差异(OR 0.31,95%CI 0.09-1.01,P=.052)。
关键数值与推荐
- 闭合型支架的自由网孔面积<5 mm²,开放型支架≥5 mm²。
- 原发性病变中开放型支架围手术期卒中或死亡3.5/100例(95%CI 2.6-4.7)vs 闭合型支架2.2%(95%CI 1.6-3.0),OR 1.59(95%CI 1.13-2.23,P<.01)。
- 再狭窄病变中开放型支架围手术期卒中或死亡1.2%(95%CI 0.4-3.3)vs 闭合型支架4.0%(95%CI 2.2-7.2),OR 0.31(95%CI 0.09-1.01,P=.052)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Intraprocedural atheroembolization during carotid artery stenting (CAS) can be reduced through careful patient selection, consideration of vascular anatomy and lesion characteristics, operator and institutional experience, peri-procedural antithrombotic and antiplatelet therapy, and use of embolic protection. However, CAS can also result in stroke as the stent is deployed and embolic protection withdrawn. The free-cell area of most closed-cell stents is <5 mm2, and ≥5 mm2 for open-cell stents. The larger area may permit escape of more atheromatous debris. Comparisons of clinical outcomes between closed-cell and open-cell stents have been inconclusive. The aim of this study is to compare clinical outcomes associated with CAS using open-cell vs closed-cell stents. METHODS: The CREST-2-Registry (C2R) enrolls asymptomatic and symptomatic patients for whom CAS is favored because of high risk for surgery or patient preference. C2R implements operator- and site-credentialing, careful lesion selection, and standardized procedural protocols. Patient characteristics, procedural details, and outcomes are recorded. Interventionists may use United States Food and Drug Administration-approved devices including open-cell stents (Rx Acculink [Abbott Vascular], Precise Pro Rx [Cordis-Cardinal Health], and Protégé Rx [Medtronic/Covidien]), or closed-cell stents (XACT [Abbott Vascular] and Wallstent Monorail Endoprosthesis [Boston Scientific]). Multivariable logistic regression was used to assess relate stent cell configuration to peri-procedural (30-day) stroke or death (SD). RESULTS: Of 5307 procedures performed by 163 interventionists across 101 clinical centers, 2054 (38.7%) received open-cell stents, and 3253 (61.3%) received closed-cell stents. In the periprocedural period, 91 patients (1.7%) experienced a stroke (3 were fatal), and 16 patients died without experiencing strokes (0.4%). After adjusting for age, sex, symptomatic status, and case urgency, and for effect-modification by indication, periprocedural SD was significantly higher when an open-cell stent was placed in a primary lesion compared with closed-cell stents (3.5 events per 100 procedures using open-cell stents [95% confidence interval [CI], 2.6-4.7] vs 2.2% [95% CI, 1.6-3.0] using closed-cell stents (odds ratio, 1.59; 95% CI, 1.13-2.23; P < .01). Periprocedural SD was not significantly different between stent types when placed in a restenotic lesion (1.2% [95% CI, 0.4-3.3]) using open-cell stents vs 4.0% (95% CI, 2.2-7.2) using closed-cell stents (odds ratio, 0.31; 95% CI, 0.09-1.01; P = .052). CONCLUSIONS: Stent design influences periprocedural stroke or death in carotid stenting. Closed-cell stents are associated with a lower event rate when treating primary atherosclerosis, but not in the setting of restenosis.
引用
- Lal BK, Roubin GS, Meschia JF, et al. Carotid artery stenting with open vs closed stent cell configurations in the CREST-2 Registry. J Vasc Surg. 2025. PMID: 40024381. doi:10.1016/j.jvs.2025.02.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。